Herbal Industry Research Monetary Fund Suggested In Annals
This article was originally published in The Tan Sheet
Executive Summary
The herbal supplement industry should consider pooling money in a common fund for botanical research, according to a Jan. 1 article in the Annals of Internal Medicine
You may also be interested in...
Kava Removed From UK Market; FDA Contacts Healthcare Community
The UK dietary supplement industry has agreed to the Medicines Control Agency's request that marketers, suppliers and retailers of kava products pull the supplements from store shelves
INA MVP Testing Methods To Encourage Botanicals Standardization
Analytical validation for the marker compounds terpene lactones in ginkgo biloba, lactones in kava kava, and flavonoids, hyperforin, hypericin and pseudohypericin in St. John's wort are being studied by member labs of the Institute for Nutraceutical Advancement's Methods Validation Program.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC